Pure Global AI
Disease / condition

Advanced Solid Tumors clinical trials

Free access to 464 studies10+ countriesUpdated daily123 recruiting
VerifiedClinicalTrials.gov · WHO ICTRP · regional registries
464
Total trials
10+
Countries
10+
Sponsors
123
Recruiting
By phase
Phase 1358
Phase 1/242
Early Phase 125
N/A22
Phase 217
By status
Completed173
Recruiting123
Not yet recruit...74
Terminated39
Unknown23
Top countries
United States of America120
China113
Japan15
Australia13
United Kingdom,United States of America9
Top sponsors
Novartis Pharmaceu...15
Pfizer12
Bristol-Myers Squi...12
Amgen10
MedImmune LLC9
Recent trials
Latest clinical trials for Advanced Solid Tumors
AMT-676 in Patients With Advanced Solid Tumors
Multitude Therapeutics Inc. · Australia
NCT06400485Not yet recr...
Phase
Phase 1
A Trial of SHR-A2102 With or Without Antitumor Therapy in Advanced Solid Tumors
Shanghai Hengrui Pharmaceutica...
NCT06417554Not yet recr...
Phase
Phase 1/2
A Phase 1 Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201 in Advanced Solid Tumors
MediLink Therapeutics (Suzhou)... · China
NCT06394414Not yet recr...
Phase
Phase 1
The Clinical Study of SHR-7631 for Injection in Patients With Advanced Solid Tumors
Suzhou Suncadia Biopharmaceuti... · China
NCT06381050Not yet recr...
Phase
Phase 1
An Evaluation of BAT 8010 for Injection in Combination With BAT 1006 in Locally Advanced or Metastatic Entities Safety, Tolerability, Pharmacokinetic Profile, and Initial Clinical Efficacy of the Tumor in Patients Multicenter, Open Phase Ib/IIa Clinical Study
Bio-Thera Solutions
NCT06376136Not yet recr...
Phase
Phase 1/2
BM201 in Combination With Radiotherapy in Patients With Advanced Solid Tumors
InnoBM Pharmaceuticals Co., Lt... · China
NCT06368960Recruiting
Phase
Phase 1
Phase 1 Trial of KH801
Beijing Kanghong Biopharmaceut... · China
NCT06364501Not yet recr...
Phase
Phase 1
A Phase I Study to Evaluate the Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors
MediLink Therapeutics (Suzhou)... · United States of America
NCT06384352Recruiting
Phase
Phase 1
HS-20089 Combination Treatment in Subjects With Advanced Solid Tumors
Hansoh BioMedical R&D Company
NCT06336707Not yet recr...
Phase
Phase 1
A Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of the Combination of BAT8008 With BAT1308 in Patients With Advanced Solid Tumors
Bio-Thera Solutions · China
NCT06341114Recruiting
Phase
Phase 1/2
Study of SIM0501 Alone and in Combination in Patients With Advanced Solid Tumors
Jiangsu Simcere Pharmaceutical... · China
NCT06331559Recruiting
Phase
Phase 1
A Phase Ia/Ib Study of GH2616 Tablet in Subjects With Advanced Solid Tumors
Suzhou Genhouse Bio Co., Ltd. · China
NCT06329206Recruiting
Phase
Phase 1
A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors
Johnson & Johnson Enterprise I... · United States of America
NCT06311578Recruiting
Phase
Phase 1
A Study for HSK39775 in Participants With Solid Tumors
Xizang Haisco Pharmaceutical C... · China
NCT06314373Recruiting
Phase
Phase 1/2
Safety and Efficacy of MK-1200 in Participants With Advanced Solid Tumors
Merck Sharp & Dohme LLC · Israel,United States of America
NCT06242691Recruiting
Phase
Phase 2
A Study of LY3537982 in Chinese Participants With Advanced Solid Tumors
Eli Lilly and Company · China
NCT06235983Not yet recr...
Phase
Phase 1
Study of ACR246 in Advanced Solid Tumors
Hangzhou Adcoris Biopharmacy C...
NCT06238401Not yet recr...
Phase
Phase 1
A First-in-human Study of GENA-104A16 in Patients With Advanced Solid Tumors
Genome & Company · South Korea
NCT06235541Not yet recr...
Phase
Phase 1
A Clinical Study of T3011 in Combination With PD-1/PD-L1 Inhibitors in Subjects With Advanced Solid Tumors
Shanghai Pharmaceuticals Holdi... · China
NCT06214143Recruiting
Phase
Phase 1/2
A Clinical Study of JS105 in Combination With Other Anti-tumor Therapies in Patients With Solid Tumors
Risen (Suzhou) Pharma Tech Co.... · China
NCT06208410Recruiting
Phase
Phase 1/2
About this profile

Access comprehensive clinical trial information for Advanced Solid Tumors through Pure Global AI's free database. This collection includes 464 clinical trials across multiple phases including Phase 1, Phase 1/2, Early Phase 1. Currently, 123 trials are actively recruiting participants.

Research for Advanced Solid Tumors is being conducted in United States of America, China, Japan and 7+ other countries. Leading sponsors include Novartis Pharmaceuticals and Pfizer. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 464 clinical trials studying Advanced Solid Tumors, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include Novartis Pharmaceuticals, Pfizer, Bristol-Myers Squibb, among others.